A Survey on Association of P16 Protein and Uterine Cervical Dysplasia

Document Type : Original Article(s)

Authors

1 Assistant Professor of Pathology, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

2 Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

3 Pathologist, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Abstract

Background: Cervical (uterine) carcinoma is the second most frequent type of women cancer. Success in early diagnosis of this disease is due to the use of pap-smear test. However, this test has both false-positive and false-negative results. P16 protein is a Cyclin-dependent Kinase inhibitor supposed to be overexpressed in cervical dysplasia and cancer. Our study was about correlation between P16 and cervical dysplasia.Methods: In this study 45 patients with dysplastic abnormalities in cervix (including Ascus-H) were sampled for papsmear (by Liquid-base method). Two smears were stained, one with papanicolau and the other (by IHC) for P16. The results were compared using t-test via SPSS15 software.Finding: Pap-stain revealed 13 ASCUS (29%), 18 LSIL (40%), 11 HSIL (24%), and 3 S.C.C (7%). Immunostaining of P16 protein was observed in ASCUS (3/13, 23%), LSIL (12/18, 67%), HSIL (11/11, 100%), and S.C.C (3/3, 100%). P16 had significant correlation with degree of cervical dysplasia in Liquid-base pap-smear (P < 0.0001).Conclusion: We suggest the usage of P16-test as an optional test for cervical dysplasia according to our study.

Keywords

References

  1. Konya J, Veress G, Hernadi Z, Soos G, Czegledy J, Gergely L. Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias. J Med Virol 1995; 46(1): 1-6.
  2. Rosai j. Rosai and Ackerman's Surgical Pathology. 9th ed. St. Louis, Missouri: Mosby; 2004.
  3. Kumar V, Cotran RS, Robbins SL. Robbins Basic Pathology. 8th ed. Philadelphia: WB. Saunders; 2007.
  4. Cotran RS, Kumar V, Collins T. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB. Saunders; 2005.
  5. Johnson LD, Nickerson RJ, Easterday CL, Stuart RS, Hertig AT. Epidemiologic evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancer. Cancer 1968; 22(5): 901-14.
  6. Gray W. Diagnostic Cytopathology. 2nd ed. Philadelphia: Churchill Livingstone; 2002.
  7. Berek JS, Editor. Berek & Novak's Gynecology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
  8. Salehi R, Shafaee P. prevalence of HPV infec-tion in cervical cancer samples. Journal of Urmia University of Medical Sciences, 2001; 12(1): 160.
  9. Zhou XB, Guo M, Quan LP, Zhang W, Lu ZM, Wang QH, et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003; 9(6): 1170-3.
  10. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6(6): 387-400.
  11. Bibbo M, Klump WJ, DeCecco J, Kovatich AJ. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol 2002; 46(1): 25-9.
  12. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153(6): 1741-8.
  13. Pietong C, Ekalaksananan T, Kongyingyoes B. Immunocytochemical staining of p16ink4A protein from conventional pap test and its association with human-papillomavirus infection. Diagn
  14. Cytopathol 2004; 31: 235-42.
  15. Geyer J, Marino J. Evaluation of Liquid-PrepTM Encapsulation Method for Liquid-Based Cytology Cell Loss Estimates during Processing. Proceedings of the 15th International Congress of Cytology. 2004 April 11–15; Santiago, Chile.
  16. Volgareva G, Zavalish ina L, Andreeva Y, Frank G, Krutikova E, Golovina D, et al. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 2004; 4: 58.
  17. Saqi A, Pasha T. Overxpression of P16INK4a in liquid-base specimen (Sur path) as marker of cervical dysplasia and neoplasia. Diagno Cytopathology 2002; 27(6): 365-70.
  18. Kurman RJ, Solomon D, Luff R, Henson D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria and Explanatory Notes for Terminology and Specimen Adequacy. Berlin: Springer-Verlag Berlin and Heidelberg GmbH & Co; 1994.
Journal of Isfahan Medical School
Volume 28, Issue 118 - Serial Number 118
November and December 2011
Pages 1207-1213

Files

History

  • Receive Date: 06 February 2011
  • Revise Date: 25 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics